{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:29:53Z","timestamp":1793316593771,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010607","name":"Universit\u00e0 degli Studi di Perugia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010607","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>SARS-CoV-2 infection is characterized by a protean clinical picture that can range from asymptomatic patients to life-threatening conditions. Severe COVID-19 patients often display a severe pulmonary involvement and develop neutrophilia, lymphopenia, and strikingly elevated levels of IL-6. There is an over-exuberant cytokine release with hyperferritinemia leading to the idea that COVID-19 is part of the hyperferritinemic syndrome spectrum. Indeed, very high levels of ferritin can occur in other diseases including hemophagocytic lymphohistiocytosis, macrophage activation syndrome, adult-onset Still\u2019s disease, catastrophic antiphospholipid syndrome and septic shock. Numerous studies have demonstrated the immunomodulatory effects of ferritin and its association with mortality and sustained inflammatory process. High levels of free iron are harmful in tissues, especially through the redox damage that can lead to fibrosis. Iron chelation represents a pillar in the treatment of iron overload. In addition, it was proven to have an anti-viral and anti-fibrotic activity. Herein, we analyse the pathogenic role of ferritin and iron during SARS-CoV-2 infection and propose iron depletion therapy as a novel therapeutic approach in the COVID-19 pandemic.<\/jats:p>","DOI":"10.1007\/s12026-020-09145-5","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T14:24:20Z","timestamp":1594995860000},"page":"213-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":166,"title":["COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4771-6981","authenticated-orcid":false,"given":"Carlo","family":"Perricone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bursi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Cafaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo Maria","family":"Guidelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"9145_CR1","doi-asserted-by":"publisher","unstructured":"Guan W, Ni Z, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. [Online ahead of print]. https:\/\/doi.org\/10.1056\/NEJMoa2002032.","DOI":"10.1056\/NEJMoa2002032"},{"key":"9145_CR2","doi-asserted-by":"publisher","unstructured":"Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020. [Online ahead of print]. https:\/\/doi.org\/10.1001\/jama.2020.378.","DOI":"10.1001\/jama.2020.378"},{"key":"9145_CR3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054\u201362.","journal-title":"Lancet"},{"key":"9145_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","volume":"136","author":"CK Wong","year":"2004","unstructured":"Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136:95\u2013103.","journal-title":"Clin Exp Immunol"},{"key":"9145_CR5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","volume":"76","author":"JR Tisoncik","year":"2012","unstructured":"Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76:16\u201332.","journal-title":"Microbiol Mol Biol Rev"},{"key":"9145_CR6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/423808","volume":"39","author":"WK Wang","year":"2004","unstructured":"Wang WK, Chen SY, Liu IJ, Kao CL, Chen HL, Chiang BL, et al. Severe acute respiratory syndrome research Group of the National Taiwan University College of Medicine\/NTU Hospital. Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome. Clin Infect Dis. 2004;39:1071\u20135.","journal-title":"Clin Infect Dis"},{"key":"9145_CR7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u20133.","journal-title":"Nature"},{"key":"9145_CR8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5:562\u20139.","journal-title":"Nat Microbiol"},{"key":"9145_CR9","first-page":"1","volume":"34","author":"P Conti","year":"2020","unstructured":"Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34:1.","journal-title":"J Biol Regul Homeost Agents"},{"key":"9145_CR10","first-page":"394","volume":"80","author":"YH Xu","year":"2020","unstructured":"Xu YH, Dong JH, An WM, Lv XY, Yin XP, Zhang JZ, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Inf Secur. 2020;80:394\u2013400.","journal-title":"J Inf Secur"},{"key":"9145_CR11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"R Channappanavar","year":"2017","unstructured":"Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529\u201339.","journal-title":"Semin Immunopathol"},{"key":"9145_CR12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/2326-6066.CIR-14-0022","volume":"2","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Kishimoto T. The biology and medical implications of interleukin-6. Cancer Immunol Res. 2014;2:288\u201394.","journal-title":"Cancer Immunol Res"},{"key":"9145_CR13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2013.10.004","volume":"343","author":"XJ Xu","year":"2014","unstructured":"Xu XJ, Tang YM. Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cells. Cancer Lett. 2014;343:172\u20138.","journal-title":"Cancer Lett"},{"key":"9145_CR14","unstructured":"Xiaoling Xu, Mingfeng Han, Tiantian Li, et al. Effective treatment of severe COVID-19 patients with tocilizumab. ChinaXiv: 202003.00026v1; TOCIVID-19."},{"key":"9145_CR15","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. HLH across speciality collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033\u20134.","journal-title":"Lancet"},{"key":"9145_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2019.00055","volume":"10","author":"E Karakike","year":"2019","unstructured":"Karakike E, Giamarellos-Bourboulis EJ. Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis. Front Immunol. 2019;10:55.","journal-title":"Front Immunol"},{"key":"9145_CR17","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846\u20138. https:\/\/doi.org\/10.1007\/s00134-020-05991-x.","journal-title":"Intensive Care Med"},{"key":"9145_CR18","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","volume":"99","author":"FM Torti","year":"2002","unstructured":"Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002;99:3505\u201316.","journal-title":"Blood"},{"key":"9145_CR19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.autrev.2007.01.016","volume":"6","author":"G Zandman-Goddard","year":"2007","unstructured":"Zandman-Goddard G, Shoenfeld Y. Ferritin in autoimmune diseases. Autoimmun Rev. 2007;6:457\u201363.","journal-title":"Autoimmun Rev"},{"key":"9145_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12016-011-8264-0","volume":"44","author":"G Zandman-Goddard","year":"2011","unstructured":"Zandman-Goddard G, Orbach H, Agmon-Levin N, Boaz M, Amital H, Szekanecz Z, et al. Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients. Clin Rev Allergy Immunol. 2011;44:23\u201330.","journal-title":"Clin Rev Allergy Immunol"},{"key":"9145_CR21","first-page":"91","volume":"13","author":"R Da Costa","year":"2011","unstructured":"Da Costa R, Szyper-Kravitz M, Szekanecz Z, Csepany T, Danko K, Shapira Y, et al. Ferritin and prolactin levels in multiple sclerosis. Isr Med Assoc J. 2011;13:91\u20135.","journal-title":"Isr Med Assoc J"},{"key":"9145_CR22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1398.044","volume":"1109","author":"H Orbach","year":"2007","unstructured":"Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci. 2007;1109:385\u2013400.","journal-title":"Ann N Y Acad Sci"},{"key":"9145_CR23","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1097\/PCC.0b013e31820abca8","volume":"12","author":"TD Bennett","year":"2011","unstructured":"Bennett TD, Hayward KN, Farris RW, Ringold S, Wallace CA, Brogan TV. Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients. Pediatr Crit Care Med. 2011;12:e233\u20136.","journal-title":"Pediatr Crit Care Med"},{"key":"9145_CR24","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1651-2227.2007.00564.x","volume":"96","author":"PC Garcia","year":"2007","unstructured":"Garcia PC, Longhi F, Branco RG, Piva JP, Lacks D, Tasker RC. Ferritin levels in children with severe sepsis and septic shock. Acta Paediatr. 2007;96:1829\u201331.","journal-title":"Acta Paediatr"},{"key":"9145_CR25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PCC.0b013e3181a1ae08","volume":"10","author":"L Castillo","year":"2009","unstructured":"Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis\/ systemic inflammatory response syndrome\/multiorgan dysfunction syndrome\/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med. 2009;10:387\u201392.","journal-title":"Pediatr Crit Care Med"},{"issue":"11","key":"9145_CR26","doi-asserted-by":"crossref","first-page":"e1045","DOI":"10.1097\/CCM.0000000000001878","volume":"44","author":"S Grang\u00e9","year":"2016","unstructured":"Grang\u00e9 S, Buchonnet G, Besnier E, Artaud-Macari E, Beduneau G, Carpentier D, et al. The use of ferritin to identify critically ill patients with secondary hemophagocytic lymphohistiocytosis. Crit Care Med. 2016 Nov;44(11):e1045\u201353.","journal-title":"Crit Care Med"},{"issue":"4","key":"9145_CR27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/CCM.0000000000004131","volume":"48","author":"G Lachmann","year":"2020","unstructured":"Lachmann G, Knaak C, Vorderw\u00fclbecke G, la Ros\u00e9e P, Balzer F, Schenk T, et al. Hyperferritinemia in critically ill patients. Crit Care Med. 2020;48(4):459\u201365.","journal-title":"Crit Care Med"},{"key":"9145_CR28","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s10067-015-3040-9","volume":"34","author":"JF Betancur","year":"2015","unstructured":"Betancur JF, Navarro EP, Echeverry A, Moncada PA, Ca\u00f1as CA, Tob\u00f3n GJ. Hyperferritinemic syndrome: Still's disease and catastrophic antiphospholipid syndrome triggered by fulminant Chikungunya infection: a case report of two patients. Clin Rheumatol. 2015;34:1989\u201392.","journal-title":"Clin Rheumatol"},{"key":"9145_CR29","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00432-020-03139-4","volume":"146","author":"S Birndt","year":"2020","unstructured":"Birndt S, Schenk T, Heinevetter B, Brunkhorst FM, Maschmeyer G, Rothmann F, et al. Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry. J Cancer Res Clin Oncol. 2020;146:1065\u201377.","journal-title":"J Cancer Res Clin Oncol"},{"key":"9145_CR30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/intimm\/dxy012","volume":"30","author":"GS Schulert","year":"2018","unstructured":"Schulert GS, Canna SW. Convergent pathways of the hyperferritinemic syndromes. Int Immunol. 2018;30:195\u2013203.","journal-title":"Int Immunol"},{"key":"9145_CR31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cei.12826","volume":"186","author":"P Ruscitti","year":"2016","unstructured":"Ruscitti P, Cipriani P, Ciccia F, Di Benedetto P, Liakouli V, Berardicurti O, et al. H-ferritin and CD68(+) \/H-ferritin(+) monocytes\/macrophages are increased in the skin of adult-onset Still\u2019s disease patients and correlate with the multi-visceral involvement of the disease. Clin Exp Immunol. 2016;186:30\u20138.","journal-title":"Clin Exp Immunol"},{"key":"9145_CR32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","volume":"11","author":"C Ros\u00e1rio","year":"2013","unstructured":"Ros\u00e1rio C, Zandman-Goddard G, Meyron-Holtz EG, D'Cruz DP, Shoenfeld Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013;11:185.","journal-title":"BMC Med"},{"key":"9145_CR33","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/PCC.0000000000000460","volume":"16","author":"JA Carcillo","year":"2015","unstructured":"Carcillo JA, Simon DW, Podd BS. How we manage hyperferritinemic sepsis-related multiple organ dysfunction syndrome\/macrophage activation syndrome\/secondary hemophagocytic lymphohistiocytosis histiocytosis. Pediatr Crit Care Med. 2015;16:598\u2013600.","journal-title":"Pediatr Crit Care Med"},{"key":"9145_CR34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.amjms.2017.04.016","volume":"354","author":"M Schaffner","year":"2017","unstructured":"Schaffner M, Rosenstein L, Ballas Z, Suneja M. Significance of hyperferritinemia in hospitalized adults. Am J Med Sci. 2017;354:152\u20138.","journal-title":"Am J Med Sci"},{"issue":"2","key":"9145_CR35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12185-015-1813-1","volume":"102","author":"H Saeed","year":"2015","unstructured":"Saeed H, Woods RR, Lester J, Herzig R, Gul Z, Monohan G. Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting. Int J Hematol. 2015;102(2):195\u20139.","journal-title":"Int J Hematol"},{"key":"9145_CR36","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Ros\u00e9e","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133:2465\u201377.","journal-title":"Blood"},{"key":"9145_CR37","doi-asserted-by":"crossref","first-page":"59977","DOI":"10.18632\/oncotarget.19230","volume":"8","author":"H Wang","year":"2017","unstructured":"Wang H, Xiong L, Tang W, Zhou Y, Li F. A systematic review of malignancy-associated hemophagocytic lymphohistiocytosis that needs more attentions. Oncotarget. 2017;8:59977\u201385.","journal-title":"Oncotarget"},{"key":"9145_CR38","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1651-2227.2009.01647.x","volume":"99","author":"O Danhaive","year":"2010","unstructured":"Danhaive O, Caniglia M, Devito R, Piersigilli F, Corchia C, Auriti C. Neonatal liver failure and haemophagocytic lymphohistiocytosis caused by a new perforin mutation. Acta Paediatr. 2010;99:778\u201380.","journal-title":"Acta Paediatr"},{"key":"9145_CR39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.23911","volume":"90","author":"ZK Otrock","year":"2015","unstructured":"Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol. 2015;90:220\u20134.","journal-title":"Am J Hematol"},{"key":"9145_CR40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/ACI.0000000000000396","volume":"17","author":"N Romberg","year":"2017","unstructured":"Romberg N, Vogel TP, Canna SW. NLRC4 inflammasomopathies. Curr Opin Allergy Clin Immunol. 2017;17:398\u2013404.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"9145_CR41","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ng.3066","volume":"46","author":"N Romberg","year":"2014","unstructured":"Romberg N, Al Moussawi K, Nelson-Williams C, Stiegler AL, Loring E, Choi M, et al. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet. 2014;46:1135\u20139.","journal-title":"Nat Genet"},{"key":"9145_CR42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.coi.2017.08.004","volume":"49","author":"FE Sepulveda","year":"2017","unstructured":"Sepulveda FE, de Saint Basile G. Hemophagocytic syndrome: primary forms and predisposing conditions. Curr Opin Immunol. 2017;49:20\u20136.","journal-title":"Curr Opin Immunol"},{"key":"9145_CR43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/bjh.13462","volume":"170","author":"K Lehmberg","year":"2015","unstructured":"Lehmberg K, Sprekels B, Nichols KE, Woessmann W, M\u00fcller I, Suttorp M, et al. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents. Br J Haematol. 2015;170:539\u201349.","journal-title":"Br J Haematol"},{"key":"9145_CR44","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","volume":"121","author":"EM Behrens","year":"2011","unstructured":"Behrens EM, Canna SW, Slade K, Rao S, Kreiger PA, Paessler M, et al. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest. 2011;121:2264\u201377.","journal-title":"J Clin Invest"},{"key":"9145_CR45","doi-asserted-by":"crossref","first-page":"e12210","DOI":"10.1097\/MD.0000000000012210","volume":"97","author":"YB Choi","year":"2018","unstructured":"Choi YB, Yi DY. Fatal case of hemophagocytic lymphohistiocytosis associated with group B streptococcus sepsis: a case report. Medicine (Baltimore). 2018;97:e12210.","journal-title":"Medicine (Baltimore)"},{"key":"9145_CR46","doi-asserted-by":"crossref","first-page":"102747","DOI":"10.1016\/j.transci.2020.102747","volume":"28","author":"B Sa\u011flam","year":"2020","unstructured":"Sa\u011flam B, Albayrak M, Acar A, Y\u0131ld\u0131z A, Maral S, T\u0131\u011fl\u0131o\u011flu M, et al. Q fever as a rare cause of hemophagocytic lymphohistiocytosis: case report. Transfus Apher Sci. 2020;28:102747.","journal-title":"Transfus Apher Sci"},{"key":"9145_CR47","first-page":"e00738","volume":"20","author":"Y Miyoshi","year":"2020","unstructured":"Miyoshi Y, Yoshioka S, Gosho H, Miyazoe S, Suenaga H, Aoki M, et al. A neonatal case of coxsackievirus B3 vertical infection with symptoms of hemophagocytic lymphohistiocytosis. ID Cases. 2020;20:e00738.","journal-title":"ID Cases"},{"key":"9145_CR48","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.autrev.2017.05.010","volume":"16","author":"PE Gavand","year":"2017","unstructured":"Gavand PE, Serio I, Arnaud L, Costedoat-Chalumeau N, Carvelli J, Dossier A, et al. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients. Autoimmun Rev. 2017;16:743\u20139.","journal-title":"Autoimmun Rev"},{"key":"9145_CR49","doi-asserted-by":"crossref","first-page":"e18759","DOI":"10.1097\/MD.0000000000018759","volume":"99","author":"MO M\u0103rginean","year":"2020","unstructured":"M\u0103rginean MO, Molnar E, Chince\u015fan MI. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a small child: a case report. Medicine (Baltimore). 2020;99:e18759.","journal-title":"Medicine (Baltimore)"},{"key":"9145_CR50","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1182\/blood-2005-04-1406","volume":"106","author":"HC Chuang","year":"2005","unstructured":"Chuang HC, Lay JD, Hsieh WC, Wang HC, Chang Y, Chuang SE, et al. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood. 2005;106:3090\u20136.","journal-title":"Blood"},{"key":"9145_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0929-6646(09)60102-9","volume":"105","author":"YC Hsieh","year":"2006","unstructured":"Hsieh YC, Wu TZ, Liu DP, Shao PL, Chang LY, Lu CY, et al. Influenza pandemics: past, present and future. J Formos Med Assoc. 2006;105:1\u20136.","journal-title":"J Formos Med Assoc"},{"key":"9145_CR52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12250-016-3918-y","volume":"32","author":"H Mao","year":"2017","unstructured":"Mao H, Liu Y, Sia SF, Peiris JSM, Lau YL, Tu W. Avian influenza virus directly infects human natural killer cells and inhibits cell activity. Virol Sin. 2017;32:122\u20139.","journal-title":"Virol Sin"},{"key":"9145_CR53","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3389\/fimmu.2017.01102","volume":"8","author":"E Brisse","year":"2017","unstructured":"Brisse E, Wouters CH, Andrei G, Matthys P. How viruses contribute to the pathogenesis of hemophagocytic lymphohistiocytosis. Front Immunol. 2017;8:1102.","journal-title":"Front Immunol"},{"key":"9145_CR54","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","volume":"130","author":"E Bergsten","year":"2017","unstructured":"Bergsten E, Horne A, Aric\u00f3 M, Astigarraga I, Egeler RM, Filipovich AH, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017;130:2728\u201338.","journal-title":"Blood"},{"key":"9145_CR55","first-page":"3879148","volume":"2019","author":"DTV Gauiran","year":"2019","unstructured":"Gauiran DTV, Cheng PVCY, Pagaduan CRP, Santos MCM. Autoimmune-associated hemophagocytosis and myelofibrosis in a newly diagnosed lupus patient: case report and literature review. Case Rep Hematol. 2019;2019:3879148.","journal-title":"Case Rep Hematol"},{"key":"9145_CR56","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1177\/0961203313504633","volume":"22","author":"N Agmon-Levin","year":"2013","unstructured":"Agmon-Levin N, Ros\u00e1rio C, Katz BS, Zandman-Goddard G, Meroni P, Cervera R, et al. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS). Lupus. 2013;22:1327\u201335.","journal-title":"Lupus"},{"key":"9145_CR57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12016-011-8264-0","volume":"44","author":"G Zandman-Goddard","year":"2013","unstructured":"Zandman-Goddard G, Orbach H, Agmon-Levin N, Boaz M, Amital H, Szekanecz Z, et al. Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients. Clin Rev Allergy Immunol. 2013;44:23\u201330.","journal-title":"Clin Rev Allergy Immunol"},{"key":"9145_CR58","doi-asserted-by":"publisher","unstructured":"Campbell CM, Kahwash R. Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? Circulation 2020;[Online ahead of print]. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047419.","DOI":"10.1161\/CIRCULATIONAHA.120.047419"},{"key":"9145_CR59","doi-asserted-by":"publisher","unstructured":"Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020;[Online ahead of print]. https:\/\/doi.org\/10.1056\/NEJMc2007575.","DOI":"10.1056\/NEJMc2007575"},{"key":"9145_CR60","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00134-016-4600-4","volume":"42","author":"M Singer","year":"2016","unstructured":"Singer M. The new sepsis consensus definitions (Sepsis-3): the good, the not-so-bad, and the actually-quite-pretty. Intensive Care Med. 2016;42:2027\u20139.","journal-title":"Intensive Care Med"},{"issue":"6","key":"9145_CR61","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/SHK.0000000000001454","volume":"53","author":"C Knaak","year":"2020","unstructured":"Knaak C, Schuster FS, Spies C, Vorderw\u00fclbecke G, Nyvlt P, Schenk T, et al. Hemophagocytic lymphohistiocytosis in critically ill patients. Shock. 2020;53(6):701\u20139.","journal-title":"Shock."},{"key":"9145_CR62","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpeds.2019.06.033","volume":"213","author":"DW Simon","year":"2019","unstructured":"Simon DW, Halstead ES, Davila S, Kernan KF, Clark RSB, Storch G, et al. DNA viremia is associated with hyperferritinemia in pediatric sepsis. J Pediatr. 2019;213:82\u201387.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2019.06.033.","journal-title":"J Pediatr"},{"key":"9145_CR63","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/cei.13057","volume":"191","author":"P Ruscitti","year":"2018","unstructured":"Ruscitti P, Cipriani P, Di Benedetto P, Liakouli V, Berardicurti O, Carubbi F, et al. H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome. Clin Exp Immunol. 2018;191:220\u20138.","journal-title":"Clin Exp Immunol"},{"key":"9145_CR64","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/hep.22716","volume":"49","author":"RG Ruddell","year":"2009","unstructured":"Ruddell RG, Hoang-Le D, Barwood JM, Rutherford PS, Piva TJ, Watters DJ, et al. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology. 2009;49:887\u2013900.","journal-title":"Hepatology"},{"key":"9145_CR65","doi-asserted-by":"crossref","first-page":"37616","DOI":"10.1074\/jbc.M607266200","volume":"281","author":"R Li","year":"2006","unstructured":"Li R, Luo C, Mines M, Zhang J, Fan GH. Chemokine CXCL12 induces binding of ferritin heavy chain to the chemokine receptor CXCR4, alters CXCR4 signaling, and induces phosphorylation and nuclear translocation of ferritin heavy chain. J Biol Chem. 2006;281:37616\u201327.","journal-title":"J Biol Chem"},{"key":"9145_CR66","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2007.11.003","volume":"30","author":"S Recalcati","year":"2008","unstructured":"Recalcati S, Invernizzi P, Arosio P, Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun. 2008;30:84\u20139.","journal-title":"J Autoimmun"},{"key":"9145_CR67","first-page":"760","volume":"2010","author":"W Wang","year":"1800","unstructured":"Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: past, present and future. Biochim Biophys Acta. 1800;2010:760\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"9145_CR68","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3324\/haematol.2019.232124","volume":"105","author":"C Camaschella","year":"2020","unstructured":"Camaschella C, Nai A, Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica. 2020;105:260\u201372.","journal-title":"Haematologica"},{"key":"9145_CR69","first-page":"2213","volume":"28","author":"J ten Kate","year":"2001","unstructured":"ten Kate J, Drenth JP, Kahn MF, van Deursen C. Iron saturation of serum ferritin in patients with adult onset Still's disease. J Rheumatol. 2001;28:2213\u20135.","journal-title":"J Rheumatol"},{"key":"9145_CR70","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/bs.enz.2019.08.003","volume":"45","author":"Y Khodour","year":"2019","unstructured":"Khodour Y, Kaguni LS, Stiban J. Iron-sulfur clusters in nucleic acid metabolism: varying roles of ancient cofactors. Enzymes. 2019;45:225\u201356. https:\/\/doi.org\/10.1016\/bs.enz.2019.08.003.","journal-title":"Enzymes."},{"key":"9145_CR71","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1093\/nar\/gkz409","volume":"47","author":"Z Jia","year":"2019","unstructured":"Jia Z, Liming Y, Ren Z, Wu L, Wang J, Guo J, et al. Delicate structural coordination of the severe acute respiratory syndrome coronavirus Nsp13 upon ATP hydrolysis. Nucleic Acids Res. 2019;47:6538\u201350.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"9145_CR72","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/gut.2006.113076","volume":"56","author":"M Thursz","year":"2007","unstructured":"Thursz M. Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection. Gut. 2007;56(5):613\u20134. https:\/\/doi.org\/10.1136\/gut.2006.113076.","journal-title":"Gut."},{"issue":"5","key":"9145_CR73","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/hep.20683","volume":"41","author":"A Galli","year":"2005","unstructured":"Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, Salzano R, et al. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology. 2005;41(5):1074\u201384. https:\/\/doi.org\/10.1002\/hep.20683.","journal-title":"Hepatology."},{"issue":"4 Suppl","key":"9145_CR74","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/nm1221","volume":"11","author":"SH Kaufmann","year":"2005","unstructured":"Kaufmann SH, McMichael AJ. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med. 2005;11(4 Suppl):S33\u201344. https:\/\/doi.org\/10.1038\/nm1221.","journal-title":"Nat Med"},{"issue":"6","key":"9145_CR75","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.4269\/ajtmh.18-0096","volume":"100","author":"BA Haider","year":"2019","unstructured":"Haider BA, Spiegelman D, Hertzmark E, Sando D, Duggan C, Makubi A, et al. Anemia, iron deficiency, and Iron supplementation in relation to mortality among HIV-infected patients receiving highly active antiretroviral therapy in Tanzania. Am J Trop Med Hyg. 2019;100(6):1512\u201320. https:\/\/doi.org\/10.4269\/ajtmh.18-0096.","journal-title":"Am J Trop Med Hyg"},{"key":"9145_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40588-020-00140-w","volume":"20","author":"W Liu","year":"2020","unstructured":"Liu W, Zhang S, Nekhai S, Liu S. Depriving Iron supply to the virus represents a promising adjuvant therapeutic against viral survival. Curr Clin Microbiol Rep. 2020;20:1\u20137. https:\/\/doi.org\/10.1007\/s40588-020-00140-w.","journal-title":"Curr Clin Microbiol Rep"},{"key":"9145_CR77","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4049\/jimmunol.164.1.201","volume":"164","author":"L Rigamonti","year":"2000","unstructured":"Rigamonti L, Ariotti S, Losana G, Gradini R, Russo MA, Jouanguy E, et al. Surface expression of the IFN-gamma R2 chain is regulated by intracellular trafficking in human T lymphocytes. J Immunol. 2000;164:201\u20137.","journal-title":"J Immunol"},{"key":"9145_CR78","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/j.1460-2075.1993.tb06039.x","volume":"12","author":"G Weiss","year":"1993","unstructured":"Weiss G, Goossen B, Doppler W, Fuchs D, Pantopoulos K, Werner-Felmayer G, et al. Translational regulation via iron-responsive elements by the nitric oxide\/NO-synthase pathway. EMBO J. 1993;12:3651\u20137.","journal-title":"EMBO J"},{"key":"9145_CR79","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1017\/S002966510000077X","volume":"59","author":"JH Brock","year":"2000","unstructured":"Brock JH, Mulero V. Cellular and molecular aspects of iron and immune function. Proc Nutr Soc. 2000;59:537\u201340.","journal-title":"Proc Nutr Soc"},{"key":"9145_CR80","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2004-07-2686","volume":"105","author":"G Regis","year":"2005","unstructured":"Regis G, Bosticardo M, Conti L, De Angelis S, Boselli D, Tomaino B, et al. Iron regulates T-lymphocyte sensitivity to the IFN-gamma\/STAT1 signaling pathway in vitro and in vivo. Blood. 2005;105:3214\u201321.","journal-title":"Blood"},{"key":"9145_CR81","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/cr.2008.15","volume":"18","author":"H Wang","year":"2008","unstructured":"Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, et al. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res. 2008;18:290\u2013301.","journal-title":"Cell Res"},{"key":"9145_CR82","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355\u201362. https:\/\/doi.org\/10.1038\/s41577-020-0331-4.","journal-title":"Nat Rev Immunol"},{"key":"9145_CR83","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032695","volume":"9","author":"G Lachmann","year":"2019","unstructured":"Lachmann G, Knaak C, von Haefen C, Paeschke N, Meisel C, Nyvlt P, et al. Diagnostic biomarkers for adult haemophagocytic lymphohistiocytosis in critically ill patients (HEMICU): a prospective observational study protocol. BMJ Open. 2019;9:e032695.","journal-title":"BMJ Open"},{"key":"9145_CR84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365513.2011.626868","volume":"72","author":"HJ M\u00f8ller","year":"2012","unstructured":"M\u00f8ller HJ. Soluble CD163. Scand J Clin Lab Inv. 2012;72:1\u201313.","journal-title":"Scand J Clin Lab Inv"},{"key":"9145_CR85","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4103\/0972-5229.123445","volume":"17","author":"P Vishwanath","year":"2013","unstructured":"Vishwanath P, Prashant A, Nataraj SM, Kotekar N, Doddamani P. Can soluble CD163 predict outcome of patients with acute respiratory distress from mechanical ventilation? A pilot study. Indian J Crit Care Med. 2013;17:355\u20138.","journal-title":"Indian J Crit Care Med"},{"key":"9145_CR86","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","volume":"10","author":"CB Crayne","year":"2019","unstructured":"Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of macrophage activation syndrome. Front Immunol. 2019;10:119.","journal-title":"Front Immunol"},{"key":"9145_CR87","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0609.2004.00318.x","volume":"74","author":"D Schaer","year":"2005","unstructured":"Schaer D, Schleiffenbaum B, Kurrer M, Imhof A, B\u00e4chli E, Fehr J, et al. Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. Eur J Haematol. 2005;74:6\u201310.","journal-title":"Eur J Haematol"},{"key":"9145_CR88","first-page":"1133","volume":"34","author":"EM Behrens","year":"2007","unstructured":"Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol. 2007;34:1133\u20138.","journal-title":"J Rheumatol"},{"key":"9145_CR89","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cyto.2018.05.017","volume":"110","author":"N Sakumura","year":"2018","unstructured":"Sakumura N, Shimizu M, Mizuta M, Inoue N, Nakagishi Y, Yachie A. Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis. Cytokine. 2018;110:459\u201365.","journal-title":"Cytokine"},{"key":"9145_CR90","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12026-014-8563-7","volume":"60","author":"S Colafrancesco","year":"2014","unstructured":"Colafrancesco S, Priori R, Alessandri C, Astorri E, Perricone C, Blank M, et al. sCD163 in AOSD, a biomarker for macrophage activation related to hyperferritinemia. Immunol Res. 2014;60:177\u201383.","journal-title":"Immunol Res"},{"key":"9145_CR91","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/0961203319860201","volume":"28","author":"A Nishino","year":"2019","unstructured":"Nishino A, Katsumata Y, Kawasumi H, Hirahara S, Kawaguchi Y, Yamanaka H. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus. Lupus. 2019;28:986\u201394.","journal-title":"Lupus"},{"key":"9145_CR92","first-page":"e2019008","volume":"11","author":"Z Gao","year":"2019","unstructured":"Gao Z, Wang Y, Wang J, Zhang J, Wang Z. Soluble ST2 and CD163 as potential biomarkers to differentiate primary hemophagocytic lymphohistiocytosis from macrophage activation syndrome. Mediterr J Hematol Infect Dis. 2019;11:e2019008.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"9145_CR93","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12969-020-0399-1","volume":"18","author":"M Shimizu","year":"2020","unstructured":"Shimizu M, Mizuta M, Okamoto N, Yasumi T, Iwata N, Umebayashi H, et al. Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Pediatric Rheumatol Online J. 2020;18:2.","journal-title":"Pediatric Rheumatol Online J"},{"key":"9145_CR94","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/ar4397","volume":"15","author":"JD Isaacs","year":"2013","unstructured":"Isaacs JD, Harari O, Kobold U, Lee JS, Bernasconi C. Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis. Athritis Res Ther. 2013;15:R204.","journal-title":"Athritis Res Ther"},{"key":"9145_CR95","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acr.23277","volume":"70","author":"GS Schulert","year":"2018","unstructured":"Schulert GS, Minoia F, Bohnsack J, Cron RQ, Hashad S, KonE\u2019-Paut I, et al. Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis. Arthritis Care Res. 2018;70:409\u201319.","journal-title":"Arthritis Care Res"},{"key":"9145_CR96","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.1998.tb10475.x","volume":"850","author":"C Hershko","year":"1998","unstructured":"Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann N Y Acad Sci. 1998;850:191\u2013201.","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"9145_CR97","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1182\/blood-2004-09-3468","volume":"105","author":"C Le Lan","year":"2005","unstructured":"Le Lan C, Lor\u00e9al O, Cohen T, et al. Redox active plasma iron inC282Y\/C282Y hemochromatosis. Blood. 2005;105(11):4527\u201331.","journal-title":"Blood"},{"issue":"1","key":"9145_CR98","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.critrevonc.2014.01.006","volume":"91","author":"S Temraz","year":"2014","unstructured":"Temraz S, Santini V, Musallam K, Taher A. Iron overload and chelation therapy in myelodysplastic syndromes. Crit Rev Oncol Hematol. 2014 Jul;91(1):64\u201373. https:\/\/doi.org\/10.1016\/j.critrevonc.2014.01.006.","journal-title":"Crit Rev Oncol Hematol"},{"key":"9145_CR99","doi-asserted-by":"crossref","unstructured":"Traor\u00e9 HN, Meyer D. The effect of iron overload on in vitro HIV-1 infection. J Clin Virol. 2004;(Suppl 1):S92\u20138.","DOI":"10.1016\/j.jcv.2004.09.011"},{"key":"9145_CR100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1386-6532(00)00122-0","volume":"20","author":"BS van Asbeck","year":"2001","unstructured":"van Asbeck BS, Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS, Marx JJ. Anti-HIV effect of iron chelators: different mechanisms involved. J Clin Virol. 2001;20:141\u20137.","journal-title":"J Clin Virol"},{"key":"9145_CR101","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1086\/315223","volume":"181","author":"NA Georgiou","year":"2000","unstructured":"Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS, Marx JJ, van Asbeck BS. Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J Infect Dis. 2000;181:484\u201390.","journal-title":"J Infect Dis"},{"key":"9145_CR102","doi-asserted-by":"crossref","first-page":"24301","DOI":"10.1074\/jbc.M010806200","volume":"276","author":"AM Romeo","year":"2001","unstructured":"Romeo AM, Christen L, Niles EG, Kosman DJ. Intracellular chelation of iron by bipyridyl inhibits DNA virus replication: ribonucleotide reductase maturation as a probe of intracellular iron pools. J Biol Chem. 2001;276:24301\u20138.","journal-title":"J Biol Chem"},{"key":"9145_CR103","doi-asserted-by":"crossref","first-page":"C1023","DOI":"10.1152\/ajpcell.00511.2003","volume":"287","author":"WE Crowe","year":"2004","unstructured":"Crowe WE, Maglova LM, Ponka P, Russell JM. Human cytomegalovirus-induced host cell enlargement is iron dependent. Am J Physiol Cell Physiol. 2004;287:C1023\u201330.","journal-title":"Am J Physiol Cell Physiol"},{"key":"9145_CR104","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2893.1996.tb00003.x","volume":"3","author":"Y Bayraktar","year":"1996","unstructured":"Bayraktar Y, Koseoglu T, Somner C, Kayhan B, Temizer A, Uzunalimoglu B, et al. The use of deferoxamine infusions to enhance the response rate to interferon-alpha treatment of chronic viral hepatitis B. J Viral Hepat. 1996;3:129\u201335.","journal-title":"J Viral Hepat"},{"key":"9145_CR105","first-page":"18","volume":"38","author":"F Mateos","year":"1999","unstructured":"Mateos F, Gonz\u00e1lez C, Dominguez C, Losa JE, Jimenez A, P\u00e9rez-Arellano JL. Elevated non-transferrin bound iron in the lungs of patients with Pneumocystis carinii pneumonia. J Inf Secur. 1999;38:18\u201321.","journal-title":"J Inf Secur"},{"key":"9145_CR106","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.exppara.2011.05.011","volume":"128","author":"JM Arantes","year":"2011","unstructured":"Arantes JM, Francisco AF, de Abreu Vieira PM, Silva M, Ara\u00fajo MSS, de Carvalho AT, et al. Trypanosoma cruzi: desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect. Exp Parasitol. 2011;128:401\u20138.","journal-title":"Exp Parasitol"},{"key":"9145_CR107","doi-asserted-by":"crossref","first-page":"516740","DOI":"10.1155\/2015\/516740","volume":"2015","author":"C Lehmann","year":"2015","unstructured":"Lehmann C, Islam S, Jarosch S, Zhou J, Hoskin D, Greenshields A, et al. The utility of iron chelators in the management of inflammatory disorders. Mediat Inflamm. 2015;2015:516740.","journal-title":"Mediat Inflamm"},{"issue":"Suppl 1","key":"9145_CR108","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2362.2002.0320s1084.x","volume":"32","author":"FLJ Visseren","year":"2002","unstructured":"Visseren FLJ, Verkerk MSA, van der Bruggen T, Marx JJM, van Asbeck BS, Diepersloot RJA. Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with chlamydia pneumoniae or influenza A. Eur J Clin Investig. 2002;32(Suppl 1):84\u201390.","journal-title":"Eur J Clin Investig"},{"key":"9145_CR109","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.1073\/pnas.93.17.9138","volume":"93","author":"WM Kazmierski","year":"1996","unstructured":"Kazmierski WM, Wolberg G, Wilson JG, Smith SR, Williams DS, Thorp HH, et al. Iron chelates bind nitric oxide and decrease mortality in an experimental model of septic shock. Proc Natl Acad Sci U S A. 1996;93:9138\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9145_CR110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbrc.2015.08.032","volume":"465","author":"S Wang","year":"2015","unstructured":"Wang S, Liu C, Pan S, Miao Q, Xue J, Xun J, et al. Deferoxamine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxic shock in mice. Biochem Biophys Res Commun. 2015;465:305\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"9145_CR111","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1053\/j.gastro.2011.08.022","volume":"141","author":"PC Adams","year":"2011","unstructured":"Adams PC. Chelation therapy for secondary iron overload: is the primary effect less iron or less liver fibrosis? Gastroenterology. 2011;141:1142\u20133.","journal-title":"Gastroenterology"},{"key":"9145_CR112","doi-asserted-by":"crossref","first-page":"114748","DOI":"10.1016\/j.taap.2019.114748","volume":"382","author":"N Adel","year":"2019","unstructured":"Adel N, Mantawy EM, El-Sherbiny DA, El-Demerdash E. Iron chelation by deferasirox confers protection against concanavalin A-induced liver fibrosis: a mechanistic approach. Toxicol Appl Pharmacol. 2019;382:114748.","journal-title":"Toxicol Appl Pharmacol"},{"key":"9145_CR113","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/1440-1681.12591","volume":"43","author":"A Mohammed","year":"2016","unstructured":"Mohammed A, Abd Al Haleem EN, El-Bakly WM, El-Demerdash E. Deferoxamine alleviates liver fibrosis induced by CCl4 in rats. Clin Exp Pharmacol Physiol. 2016;43:760\u20138.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9145_CR114","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bcp.2015.09.001","volume":"98","author":"SF Darwish","year":"2015","unstructured":"Darwish SF, El-Bakly WM, El-Naga RN, Awad AS, El-Demerdash E. Antifibrotic mechanism of deferoxamine in concanavalin A induced-liver fibrosis: impact on interferon therapy. Biochem Pharmacol. 2015;98:231\u201342.","journal-title":"Biochem Pharmacol"},{"key":"9145_CR115","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/jgh.12720","volume":"30","author":"A Sobbe","year":"2015","unstructured":"Sobbe A, Bridle KR, Jaskowski L, de Guzman CE, Santrampurwala N, Clouston AD, et al. Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox. J Gastroenterol Hepatol. 2015;30:638\u201345.","journal-title":"J Gastroenterol Hepatol"},{"key":"9145_CR116","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/hr.2015.60","volume":"38","author":"K Tamura","year":"2015","unstructured":"Tamura K, Uneda K, Azushima K, Wakui H, Haruhara K. Possible therapeutic impact of the iron chelation on renal fibrosis. Hypertens Res. 2015;38:455\u20136.","journal-title":"Hypertens Res"},{"key":"9145_CR117","doi-asserted-by":"crossref","first-page":"e89355","DOI":"10.1371\/journal.pone.0089355","volume":"9","author":"Y Ikeda","year":"2014","unstructured":"Ikeda Y, Ozono I, Tajima S, Imao M, Horinouchi Y, Izawa-Ishizawa Y, et al. Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction. PLoS One. 2014;9:e89355.","journal-title":"PLoS One"},{"key":"9145_CR118","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.trsl.2010.12.009","volume":"157","author":"LF Li","year":"2011","unstructured":"Li LF, Huang CC, Liu YY, Lin HC, Kao KC, Yang CT, et al. Hydroxyethyl starch reduces high stretch ventilation-augmented lung injury via vascular endothelial growth factor. Transl Res. 2011;157:293\u2013305.","journal-title":"Transl Res"},{"key":"9145_CR119","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/aps.2012.66","volume":"33","author":"LT Huang","year":"2012","unstructured":"Huang LT, Chou HC, Wang LF, Chen CM. Tissue plasminogen activator attenuates ventilator-induced lung injury in rats. Acta Pharmacol Sin. 2012;33:991\u20137.","journal-title":"Acta Pharmacol Sin"},{"key":"9145_CR120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12871-018-0576-7","volume":"18","author":"W Zhu","year":"2018","unstructured":"Zhu W, Huang Y, Ye Y, Wang Y. Deferoxamine preconditioning ameliorates mechanical ventilation-induced lung injury in rat model via ROS in alveolar macrophages: a randomized controlled study. BMC Anesthesiol. 2018;18:116.","journal-title":"BMC Anesthesiol"},{"key":"9145_CR121","doi-asserted-by":"publisher","first-page":"102468","DOI":"10.1016\/j.jaut.2020.102468","volume":"111","author":"C Perricone","year":"2020","unstructured":"Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, et al. The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19. J Autoimmun. 2020;111:102468. https:\/\/doi.org\/10.1016\/j.jaut.2020.102468.","journal-title":"J Autoimmun"},{"issue":"6","key":"9145_CR122","doi-asserted-by":"publisher","first-page":"102538","DOI":"10.1016\/j.autrev.2020.102538","volume":"19","author":"Y Shoenfeld","year":"2020","unstructured":"Shoenfeld Y. Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmun Rev. 2020;19(6):102538. https:\/\/doi.org\/10.1016\/j.autrev.2020.102538.","journal-title":"Autoimmun Rev"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09145-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-020-09145-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09145-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T23:55:01Z","timestamp":1626479701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-020-09145-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["9145"],"URL":"https:\/\/doi.org\/10.1007\/s12026-020-09145-5","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]},"assertion":[{"value":"17 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}